Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - Willis Towers Watson plc - Amendment

22nd Jul 2020 14:15

 

Ap19

FORM 8.3 - Amendment to Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)Barclays PLC.
Company dealt inWILLIS TOWERS WATSON PLC
Class of relevant security to which theORD
dealings being disclosed relate (Note 2)
Date of dealing17 July 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

ORD

 

 

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,460,361

1.13%

443,202

0.34%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

333,000

0.26%

383,659

0.30%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,793,361

1.39%

826,861

0.64%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

100

207.5200 USD

Purchase

100

208.2200 USD

Purchase

100

207.8900 USD

Purchase

100

208.7200 USD

Purchase

100

207.8400 USD

Purchase

100

207.5900 USD

Purchase

100

207.5550 USD

Purchase

103

207.2155 USD

Purchase

164

207.7539 USD

Purchase

201

207.6643 USD

Purchase

305

208.2978 USD

Purchase

349

207.6125 USD

Purchase

406

207.6522 USD

Purchase

417

207.9005 USD

Purchase

480

207.9410 USD

Purchase

500

207.6400 USD

Purchase

501

208.3778 USD

Purchase

560

207.7071 USD

Purchase

603

207.7485 USD

Purchase

656

208.1939 USD

Purchase

760

207.8121 USD

Purchase

784

207.8652 USD

Purchase

986

207.6668 USD

Purchase

1,068

207.6739 USD

Purchase

1,120

207.7051 USD

Purchase

1,400

208.1550 USD

Purchase

1,403

207.7660 USD

Purchase

1,617

208.0548 USD

Purchase

1,768

207.8993 USD

Purchase

2,336

207.7359 USD

Purchase

2,764

207.8302 USD

Purchase

3,120

207.7700 USD

Purchase

3,462

208.3622 USD

Purchase

4,917

207.7249 USD

Purchase

5,001

208.1710 USD

Purchase

5,339

208.0424 USD

Purchase

7,000

207.8794 USD

Purchase

7,441

208.5000 USD

Purchase

8,484

207.9623 USD

Purchase

9,204

207.8364 USD

Purchase

13,909

207.6782 USD

Purchase

18,055

207.9748 USD

Sale

11

207.1100 USD

Sale

20

208.7350 USD

Sale

78

207.7700 USD

Sale

100

207.0600 USD

Sale

100

206.6640 USD

Sale

100

208.5700 USD

Sale

200

208.4600 USD

Sale

240

208.5300 USD

Sale

300

208.1583 USD

Sale

368

207.3303 USD

Sale

656

208.1939 USD

Sale

1,551

208.1967 USD

Sale

2,786

208.1067 USD

Sale

3,300

208.0543 USD

Sale

4,437

208.0224 USD

Sale

5,000

208.2884 USD

Sale

5,000

207.6663 USD

Sale

6,801

207.9397 USD

Sale

8,570

208.5000 USD

Sale

17,966

207.8622 USD

Sale

18,907

207.9756 USD

Sale

31,236

207.7996 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:

22 Jul 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200722005524/en/

Copyright Business Wire 2020


Related Shares:

Barclays
FTSE 100 Latest
Value8,875.22
Change24.59